Click on a filter below to refine your search. Remove a filter to broaden your search.
The authors say that Medicare could have saved up to $3.6 billion by purchasing generics at Mark Cuban Cost Plus Drug Co. prices.
But the biggest policy change — letting Medicare negotiate prices for prescription drugs — will not start to lower costs until 2025.
For the first time, the measure would enable the federal government to negotiate prices for medications covered by Medicare.
Despite a drop in diabetes-related outpatient visits and testing, no negative association was found with glycemic control.